MannKind (MNKD) Stock Is Likely To Climb: Get In While You Can!

MannKind Corporation (NASDAQ: MNKD) MannKind is a very interesting stock in my opinion. That’s because I’ve never seen another stock invoke such emotion, debate and passion among traders. Those that are bullish on the stock are die-hard bulls and those that are bearish swear by their opinions. With that said, I’ll start by letting you … Read more

MannKind (MNKD) Provides A Presentation Tomorrow: What You Need To Know

MannKind Corporation (NASDAQ: MNKD) MannKind stock has been having an incredibly rough time lately. While the downtrends do make sense, I don’t think that they will continue for very much longer. We’ll get into that later. For now, there’s big news surrounding MNKD! Tomorrow, the company will be giving a presentation. Although, they have been … Read more

MannKind (MNKD) Stock: We’re Likely To See More Gains From Here!

MannKind Corporation (NASDAQ: MNKD) MannKind Corporation has been dealt a tough hand throughout the beginning of the year. After Afrezza came out, investors were incredibly excited. However, as time went on, impatience got the best of investors who simply couldn’t wait for sales. Soon, MNKD became one of the most heavily shorted stocks in the … Read more

MannKind (MNKD) Stock Presents More Buying Opportunities

MannKind Corporation (NASDAQ: MNKD) In my opinion, MannKind Corporation is one of the most interesting stocks in biotech today. The company has created an incredible product; something that no one has ever seen before. However, pre-launch sales just haven’t been what many expected. Ultimately, this caused the stock to go on a downtrend that still … Read more

MannKind (MNKD) Stock Holders – Get Ready For Afrezza Sales

MannKind Corporation (NASDAQ: MNKD) MannKind is a stock that I’ve followed for quite some time, and even while the market turned bearish on the stock, I’m glad that I didn’t. The reality is that MannKind is a great company with an incredible product. That product is Afrezza. Although Afrezza has been the reason for the … Read more